Patent details

EP2552210 Title: FORMULATIONS OF MAZINDOL

Basic Information

Publication number:
EP2552210
PCT Application Number:
US2011030442
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP117633487
PCT Publication Number:
WO2011123496
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FORMULATIONS OF MAZINDOL
French Title of Invention:
FORMULATIONS DE MAZINDOL
German Title of Invention:
FORMULIERUNGEN AUS MAZINDOL
SPC Number:

Dates

Filing date:
30/03/2011
Grant date:
20/12/2017
EP Publication Date:
06/02/2013
PCT Publication Date:
06/10/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/12/2017
EP B1 Publication Date:
20/12/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
30/03/2018
Expiration date:
30/03/2031
Renunciation date:
Revocation date:
20/11/2023
Annulment date:

Owner

From:
13/12/2017
 
 

Name:
Supernus Pharmaceuticals, Inc.
Address:
1550 East Gude Drive, Rockville, MD 20850, United States (US)

Inventor

1

Name:
KIDANE, Argaw
Address:
United States (US)

2

Name:
BHATT, Padmanabh, P
Address:
United States (US)

Priority

Priority Number:
282788 P
Priority Date:
31/03/2010
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/4045; A61K 31/407; A61K 31/4184; A61K 31/4188;

Publication

European Patent Bulletin

1

Issue number:
201751
Publication date:
20/12/2017
Description:
Grant (B1)

2

Issue number:
202418
Publication date:
01/05/2024
Description:
Revocation of the European patent

3

Issue number:
201804
Publication date:
24/01/2018
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
31/07/2018 Outgoing Correspondence 1